A Study of RC48-ADC in Local Advanced or Metastatic Gastric Cancer With the HER2-Overexpression
RemeGen Co., Ltd.
RemeGen Co., Ltd.
Jinling Hospital, China
LintonPharm Co.,Ltd.
Shanghai Henlius Biotech
Huazhong University of Science and Technology
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Sixth Affiliated Hospital, Sun Yat-sen University
Sixth Affiliated Hospital, Sun Yat-sen University
Taizhou Hanzhong biomedical co. LTD
Henan Cancer Hospital
Chinese University of Hong Kong
The First Affiliated Hospital of Anhui Medical University
Zhejiang Cancer Hospital
National Cancer Center, Korea
Fujian Cancer Hospital
Nanfang Hospital, Southern Medical University
Fudan University
Shanghai Zhongshan Hospital
Huazhong University of Science and Technology
Huazhong University of Science and Technology
Fudan University
West China Hospital
Tianjin Medical University Cancer Institute and Hospital
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
University Hospital Tuebingen
Dutch Colorectal Cancer Group
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
The Catholic University of Korea
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Sun Yat-sen University
Nanjing PLA General Hospital
The Catholic University of Korea
University Hospital, Clermont-Ferrand
Moscow Clinical Scientific Center
Chinese PLA General Hospital
Chinese PLA General Hospital
Sixth Affiliated Hospital, Sun Yat-sen University
Sun Yat-sen University
West China Hospital
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
Asan Medical Center
ChineseAMS
Tianjin Medical University Cancer Institute and Hospital
Peking University
Nanfang Hospital, Southern Medical University
Xinjiang Medical University
Kosin University Gospel Hospital
National Cancer Institute (NCI)
Fudan University
Tokyo Metropolitan Oncology Group